AVCN.TO
Avicanna Inc
Price:  
0.28 
CAD
Volume:  
364,582.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

-2.6%
Upside

As of 2025-05-22, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -7.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 30.28 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -3.87 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples 0.8x - 0.8x 0.8x
Fair Price 0.27 - 0.27 0.27
Upside -2.6% - -2.6% -2.6%
0.28 CAD
Stock Price
0.27 CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-14 -6.69
2025-05-12 -6.97
2025-05-09 -6.97
2025-05-08 -6.97
2025-05-07 -6.97
2025-05-06 -7.12
2025-05-05 -6.97
2025-05-02 -6.55
2025-05-01 -6.55
2025-04-30 -6.83
2025-04-29 -6.83
2025-04-28 -6.40
2025-04-25 -6.83
2025-04-24 -7.40
2025-04-23 -6.97
2025-04-22 -7.26
2025-04-21 -6.83
2025-04-17 -6.40
2025-04-16 -6.69
2025-04-15 -7.26
2025-04-14 -8.11
2025-04-11 -6.40
2025-04-10 -6.12
2025-04-09 -6.69
2025-04-08 -6.55
2025-04-07 -6.69
2025-04-04 -5.83
2025-04-03 -6.97
2025-04-02 -6.97
2025-04-01 -7.54
2025-03-31 -8.54
2025-03-28 -9.11
2025-03-27 -8.68
2025-03-26 -8.68
2025-03-25 -9.25
2025-03-24 -9.25
2025-03-21 -10.11
2025-03-20 -9.68
2025-03-19 -10.68
2025-03-18 -10.53
2025-03-17 -9.96
2025-03-14 -9.82
2025-03-13 -9.82
2025-03-12 -9.82
2025-03-11 -10.39
2025-03-10 -10.53
2025-03-07 -10.39
2025-03-06 -9.68
2025-03-05 -7.83
2025-03-04 -8.11